JP2001520886A5 - - Google Patents

Download PDF

Info

Publication number
JP2001520886A5
JP2001520886A5 JP2000518092A JP2000518092A JP2001520886A5 JP 2001520886 A5 JP2001520886 A5 JP 2001520886A5 JP 2000518092 A JP2000518092 A JP 2000518092A JP 2000518092 A JP2000518092 A JP 2000518092A JP 2001520886 A5 JP2001520886 A5 JP 2001520886A5
Authority
JP
Japan
Prior art keywords
dna
protein
amino acid
acid consensus
diagnostically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000518092A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001520886A (ja
Filing date
Publication date
Priority claimed from DE19747418A external-priority patent/DE19747418C1/de
Application filed filed Critical
Publication of JP2001520886A publication Critical patent/JP2001520886A/ja
Publication of JP2001520886A5 publication Critical patent/JP2001520886A5/ja
Pending legal-status Critical Current

Links

JP2000518092A 1997-10-27 1998-10-27 ｗｎｔシグナル経路の阻害タンパク質 Pending JP2001520886A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19747418.7 1997-10-27
DE19747418A DE19747418C1 (de) 1997-10-27 1997-10-27 Inhibitor-Protein des wnt-Signalwegs
PCT/DE1998/003155 WO1999022000A1 (de) 1997-10-27 1998-10-27 Inhibitor-protein des wnt-signalwegs

Publications (2)

Publication Number Publication Date
JP2001520886A JP2001520886A (ja) 2001-11-06
JP2001520886A5 true JP2001520886A5 (enExample) 2005-12-22

Family

ID=7846765

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000518092A Pending JP2001520886A (ja) 1997-10-27 1998-10-27 ｗｎｔシグナル経路の阻害タンパク質

Country Status (9)

Country Link
US (4) US6844422B1 (enExample)
EP (2) EP1027440B2 (enExample)
JP (1) JP2001520886A (enExample)
AT (1) ATE391782T1 (enExample)
DE (2) DE19747418C1 (enExample)
DK (1) DK1027440T3 (enExample)
ES (1) ES2306483T5 (enExample)
PT (1) PT1027440E (enExample)
WO (1) WO1999022000A1 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7057017B2 (en) 1997-04-16 2006-06-06 Millennium Pharmaceuticals, Inc. Human dickkopf-related protein and nucleic acid molecules and uses therefor
DE69837085T3 (de) * 1997-04-16 2012-01-12 Millennium Pharmaceuticals, Inc. Crsp-proteine (cystein-reiche, sekretierte proteine), die dafür kodierenden nukleinsäuren und ihre verwendungen
DE19747418C1 (de) 1997-10-27 1999-07-15 Deutsches Krebsforsch Inhibitor-Protein des wnt-Signalwegs
US7446181B2 (en) * 1998-01-15 2008-11-04 Millennium Pharmaceuticals, Inc. Antibodies that bind human Dickkopf-1 proteins
US6344541B1 (en) 1998-09-25 2002-02-05 Amgen Inc. DKR polypeptides
WO2000052047A2 (en) * 1999-03-05 2000-09-08 Millennium Pharmaceuticals, Inc. Human dickkopf-related protein and nucleic acid molecules and uses therefor
GB0013674D0 (en) * 1999-06-08 2000-07-26 Lorantis Ltd Therapeutic use
JP2003528300A (ja) * 2000-02-24 2003-09-24 オックスフォード グリコサイエンセス（ユーケー） リミテッド 神経精神及び神経障害におけるｄｐｉ−６、推定上の治療ターゲットおよびバイオマーカー
EP1222933A1 (en) * 2001-01-15 2002-07-17 Academisch Ziekenhuis Leiden h.o.d.n., Leids Universitair Medisch Centrum Generation and/or reduction of new lung tissue in an affected lung, by modulation of the Wnt-pathway
EP2280030A3 (en) 2001-04-10 2011-06-15 Agensys, Inc. Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
US7713526B2 (en) * 2001-05-01 2010-05-11 The Regents Of The University Of California Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
US20040038860A1 (en) 2002-05-17 2004-02-26 Allen Kristina M. Reagents and methods for modulating dkk-mediated interactions
IL149404A0 (en) * 2002-04-29 2002-11-10 Yissum Res Dev Co METHODS AND COMPOSITIONS FOR MODULATING β-CATENIN PHOSPHORYLATION
US20040247593A1 (en) * 2002-10-04 2004-12-09 Regents Of The University Of California, Methods for treating cancer by inhibiting Wnt signaling
US8367822B2 (en) 2003-09-22 2013-02-05 Enzo Therapeutics, Inc. Compositions and methods for bone formation and remodeling
US8461155B2 (en) * 2003-09-22 2013-06-11 University Of Connecticut Sclerostin and the inhibition of WNT signaling and bone formation
US8637506B2 (en) * 2003-09-22 2014-01-28 Enzo Biochem, Inc. Compositions and methods for bone formation and remodeling
US9046537B2 (en) 2003-09-22 2015-06-02 Enzo Biochem, Inc. Method for treating inflammation by administering a compound which binds LDL-receptor-related protein (LRP) ligand binding domain
WO2005049640A2 (en) 2003-11-17 2005-06-02 Merck & Co., Inc. Rhesus monkey dickkopf-1, nucleotides encoding same, and uses thereof
US7473770B2 (en) 2003-11-17 2009-01-06 Merck & Co., Inc. Cynomolgus monkey dickkopf-4, nucleotides encoding same, and uses thereof
WO2005095448A2 (en) * 2004-03-23 2005-10-13 Oscient Pharmaceuticals Corporation Method of synthesizing and purifying dkk proteins and dkk proteins obtained thereby
CN1981054A (zh) * 2004-05-14 2007-06-13 加利福尼亚大学董事会 用抗wnt2单克隆抗体和sirna治疗癌症的方法
US9052324B2 (en) 2004-05-19 2015-06-09 Enzo Biochem, Inc. Compounds and assays for controlling Wnt activity
US8343922B2 (en) * 2004-05-19 2013-01-01 Enzo Biochem, Inc. Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells
AU2005245021A1 (en) * 2004-05-21 2005-12-01 The Regents Of The University Of California Methods for treating and diagnosing cancer with wnt inhibitory factor-1 (wif-1)
MX2007001221A (es) 2004-08-04 2007-03-23 Amgen Inc Anticuerpos para proteina dickkopf-1 (dkk-1).
RU2392961C2 (ru) * 2004-11-10 2010-06-27 Хубрехт Лабораториум Лечение аденомы и/или аденокарциномы кишечника с помощью ингибирования активации пути notch
AU2005313020A1 (en) * 2004-12-09 2006-06-15 Neuro Therapeutics Ab Materials and methods related to Dickkopfs (DKK) and Neurogenesis
EP1795198A1 (en) * 2005-12-09 2007-06-13 Hubrecht Laboratorium Treatment of Barret's esophagus
AR060017A1 (es) 2006-01-13 2008-05-21 Novartis Ag Composiciones y metodos de uso para anticuerpos de dickkopf -1
WO2008097510A1 (en) * 2007-02-08 2008-08-14 Merck & Co., Inc. Antibodies specific for dkk-1
US20090074668A1 (en) * 2007-09-14 2009-03-19 Farjo Rafal A Vldlr-/- mouse models and related methods
AR075989A1 (es) 2009-04-10 2011-05-11 Lilly Co Eli Anticuerpo dkk -1 (dickkopf-1) humano disenado por ingenieria
WO2010129284A1 (en) * 2009-04-27 2010-11-11 The Trustees Of The University Of Pennsylvania Inhibition of hair follicle growth by the wnt inhibitor dkk1
WO2010131185A1 (en) 2009-05-12 2010-11-18 Pfizer Inc. Blocking anti-dkk-1 antibodies and their uses
US9133272B2 (en) 2011-03-01 2015-09-15 Amgen Inc. Bispecific binding agents
EP2686347B1 (en) 2011-03-16 2018-05-02 argenx BVBA Antibodies to cd70
EP2836514A4 (en) * 2012-04-13 2015-12-30 Childrens Medical Center TIKI INHIBITORS
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
US10391168B1 (en) 2014-08-22 2019-08-27 University Of Bern Anti-CD70 combination therapy
GB201800649D0 (en) 2018-01-16 2018-02-28 Argenx Bvba CD70 Combination Therapy
TWI848030B (zh) 2018-12-18 2024-07-11 比利時商阿根思公司 Ｃｄ７０組合治療

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6133232A (en) * 1996-06-20 2000-10-17 The Regents Of The University Of California Endoderm, cardiac and neural inducing factors
AU5613498A (en) 1996-12-20 1998-07-17 Human Genome Sciences, Inc. Cerebellum and embryo specific protein
US7057017B2 (en) * 1997-04-16 2006-06-06 Millennium Pharmaceuticals, Inc. Human dickkopf-related protein and nucleic acid molecules and uses therefor
DE69837085T3 (de) * 1997-04-16 2012-01-12 Millennium Pharmaceuticals, Inc. Crsp-proteine (cystein-reiche, sekretierte proteine), die dafür kodierenden nukleinsäuren und ihre verwendungen
DE19747418C1 (de) 1997-10-27 1999-07-15 Deutsches Krebsforsch Inhibitor-Protein des wnt-Signalwegs
US7446181B2 (en) * 1998-01-15 2008-11-04 Millennium Pharmaceuticals, Inc. Antibodies that bind human Dickkopf-1 proteins

Similar Documents

Publication Publication Date Title
JP2001520886A5 (enExample)
FI88175B (fi) Rekombinant-dna-molekyler och foerfaranden foer framstaellning av polypeptider liknande humant -interferon
JPH09322781A5 (enExample)
CA2196555A1 (en) Vr-2332 viral nucleotide sequence and methods of use
JP2004511201A5 (enExample)
NZ505880A (en) IL-18 receptor polypeptides
AU656159B2 (en) Cloning and expression of borrelia lipoproteins
JP2002510494A5 (enExample)
JP2004524824A5 (enExample)
WO2001066597A3 (en) Inflammation-related gene
ATE358724T1 (de) Expression regulierende sequenzen vom schimmelpilz chrysosporium
CA2216741A1 (en) A novel protein and process for preparing the same
JP2002517193A5 (enExample)
CA2441327A1 (en) Human arginine-rich protein-related compositions
KR870000501B1 (ko) 사람의 프로인슐린의 아미노산 배열을 함유하는 단백질의 제조방법
WO2001046394A3 (en) Mammalian protein phosphatases
ATE280232T1 (de) Nukleotidsequenzen, welche für das dapf-gen kodieren
WO2003050236A3 (en) Human genes and gene expression products isolated from human prostate
AU704594B2 (en) Production of recombinant peptides as natural hydrophobic peptide analogues
JP2002504333A5 (enExample)
WO1996021020A3 (en) Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases
EP0834568A3 (en) Novel saliva binding protein
WO2002068662A8 (en) Plasmid originated from bifidobacterium, recombinant expression vector using the plasmid and transformation method
WO1999054436A3 (en) Nucleic acids and proteins of c. elegans insulin-like genes and uses thereof
IL145545A0 (en) Human neurogenin 3-encoding nucleotide sequences